Business
After a successful podcast series in 2025 and panels at HIMSS25 and HIMSS26, the Project Management Institute's Karla Mae Eidem says PMI and HIMSS are planning to organize local events for project professionals.
The company will use the funds to enhance its platform, grow its workforce and expand partnerships with health systems to automate medication approval workflows.
The company will use the funds to accelerate development of its AI precision health platform.
As CMS deploys AI tools and data analysis to uncover possible Medicare and Medicaid fraud, COO Kimberly Brandt explains that suspected providers are offered education on billing rules and three chances to correct any errors.
The company acquired Intelerad for $2.3 billion in cash and debt financing and expects around $270 million in recurring annual revenue and a high-single-digit return on investment within five years.
According to CMS' Amy Gleason, the agency is inspiring innovation by offering vendors the opportunity to develop secure, CARIN code-certified patient-facing apps. These apps will be made available via the Medicare.gov website.
The company will use the funds to scale its platform, hire engineers and data scientists, deepen clinical integrations and speed the deployment of custom AI agents.
The company's lab allows AI systems to create, evaluate and deploy new machine learning models with minimal human intervention.
Proactive monitoring via wearables and at-home care can keep patients healthier longer, reducing inpatient stays and strengthening health outcomes by detecting anomalies earlier, explains Hal Wolf, HIMSS president and CEO.
The latest funding round brings the company's total raise to approximately $100 million.